Namwan, N.; Senawong, G.; Phaosiri, C.; Kumboonma, P.; Somsakeesit, L.-o.; Samankul, A.; Leerat, C.; Senawong, T.
Synergistic Anti-Cancer Activities of Curcumin Derivative CU17 Combined with Gemcitabine Against A549 Non-Small-Cell Lung Cancer Cells. Pharmaceutics 2025, 17, 158.
https://doi.org/10.3390/pharmaceutics17020158
AMA Style
Namwan N, Senawong G, Phaosiri C, Kumboonma P, Somsakeesit L-o, Samankul A, Leerat C, Senawong T.
Synergistic Anti-Cancer Activities of Curcumin Derivative CU17 Combined with Gemcitabine Against A549 Non-Small-Cell Lung Cancer Cells. Pharmaceutics. 2025; 17(2):158.
https://doi.org/10.3390/pharmaceutics17020158
Chicago/Turabian Style
Namwan, Narissara, Gulsiri Senawong, Chanokbhorn Phaosiri, Pakit Kumboonma, La-or Somsakeesit, Arunta Samankul, Chadaporn Leerat, and Thanaset Senawong.
2025. "Synergistic Anti-Cancer Activities of Curcumin Derivative CU17 Combined with Gemcitabine Against A549 Non-Small-Cell Lung Cancer Cells" Pharmaceutics 17, no. 2: 158.
https://doi.org/10.3390/pharmaceutics17020158
APA Style
Namwan, N., Senawong, G., Phaosiri, C., Kumboonma, P., Somsakeesit, L.-o., Samankul, A., Leerat, C., & Senawong, T.
(2025). Synergistic Anti-Cancer Activities of Curcumin Derivative CU17 Combined with Gemcitabine Against A549 Non-Small-Cell Lung Cancer Cells. Pharmaceutics, 17(2), 158.
https://doi.org/10.3390/pharmaceutics17020158